Literature DB >> 6856209

Type of intrauterine device and the risk of pelvic inflammatory disease.

N C Lee, G L Rubin, H W Ory, R T Burkman.   

Abstract

To study the association of pelvic inflammatory disease and various types of intrauterine devices (IUDs), data from the Women's Health Study were analyzed. The analysis included data from interviews of 622 women hospitalized with an initial episode of pelvic inflammatory disease and 2369 hospitalized control subjects reporting no history of pelvic inflammatory disease. Compared to the risk in women using no contraception, the relative risk of pelvic inflammatory disease in women currently using the Dalkon Shield was 8.3 (95% confidence limits 4.7 to 14.5). This represented a fivefold increase in risk compared to women currently using other types of IUDs. In this study, only 10% of women wearing an IUD were using the Dalkon Shield, yet they accounted for almost 20% of the excess risk of pelvic inflammatory disease occurring among all the IUD users. Most of the increased risk of pelvic inflammatory disease for women currently using other IUDs (excluding the Dalkon Shield) occurred in the first four months after insertion. These associations were not explained by differences between cases and controls in demographic variables, level of sexual activity, or medical history. The authors recommend that women still using a Dalkon Shield have it removed.

Entities:  

Mesh:

Year:  1983        PMID: 6856209

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  14 in total

Review 1.  Contraception.

Authors:  A Szarewski; J Guillebaud
Journal:  BMJ       Date:  1991-05-25

2.  Antibiotic prophylaxis in gynaecologic procedures.

Authors:  Nancy Van Eyk; Julie van Schalkwyk
Journal:  J Obstet Gynaecol Can       Date:  2012-04

Review 3.  Pelvic inflammatory disease: current concepts and treatment guidelines.

Authors:  P A Dale; P A Rice; K C Edelin
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

4.  Long-term study of the safety of the Dalkon Shield and Gyne-T 200 intrauterine devices.

Authors:  J E Rioux; D Cloutier; P Dupont; D Lamonde
Journal:  CMAJ       Date:  1986-04-01       Impact factor: 8.262

5.  Contraceptive methods and ovarian cancer risk among Chinese women: A report from the Shanghai Women's Health Study.

Authors:  Zhezhou Huang; Yutang Gao; Wanqing Wen; Honglan Li; Wei Zheng; Xiao-Ou Shu; Alicia Beeghly-Fadiel
Journal:  Int J Cancer       Date:  2015-01-21       Impact factor: 7.396

Review 6.  Contraception in Canada: a review of method choices, characteristics, adherence and approaches to counselling.

Authors:  William A Fisher; Amanda Black
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

7.  Pelvic infection: a comparison of the Dalkon shield and three other intrauterine devices.

Authors:  R Snowden; B Pearson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-26

Review 8.  Tubo-ovarian abscess: pathogenesis and management.

Authors:  N G Osborne
Journal:  J Natl Med Assoc       Date:  1986-10       Impact factor: 1.798

9.  Actinomyces naeslundii as an agent of pelvic actinomycosis in the presence of an intrauterine device.

Authors:  W Bonnez; G Lattimer; N A Mohanraj; T H Johnson
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

10.  IUD use and subsequent tubal ectopic pregnancy.

Authors:  W H Chow; J R Daling; N S Weiss; D E Moore; R M Soderstrom; B J Metch
Journal:  Am J Public Health       Date:  1986-05       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.